COMMUNIQUÉS West-GlobeNewswire

Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
03/03/2026
FRIENDSWOOD, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will host a grand [...]
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference
03/03/2026
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its [...]
LifeMD to Participate in Two Investor Conferences During March
03/03/2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences [...]
TimelyCare Honored as Virtual Student Health and Wellness Services Company of the Year 2026 by Education Insider
03/03/2026
Recognition Highlights Transformative Mental Health Outcomes and Student Retention Fort Worth, TX, March 03, 2026 (GLOBE NEWSWIRE) -- TimelyCare , education’s most trusted virtual health and well-being provider, has [...]
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026
03/03/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature handheld robotics and digital solutions for hip, knee and shoulder in addition to innovative trauma and extremities [...]
Résultats 2025 : amélioration de la marge de Core EBITDA en dépit de vents contraires sur l’activité, grâce à une stricte discipline financière
03/03/2026
Communiqué de presse Paris, le 3 mars 2026 Avancée de FOCUS-27 dans un environnement plus difficile Accélération de la transformation pour renforcer le modèle opérationnel Résultats 2025 Chiffre d’affaires de 848,2 [...]
Hypersanté Hosts First Francophone Summit on Longevity and Biohacking in Paris
03/03/2026
A $30 Billion Industry Redefining Preventive Medicine Paris, ÎLE-DE-FRANCE, March 03, 2026 (GLOBE NEWSWIRE) -- For decades, longevity sat at two opposite ends of the spectrum: cutting-edge medicine for the ultra-wealthy [...]
2025 results: Core EBITDA margin improved despite sales headwinds, driven by strong cost discipline
03/03/2026
Press Release Paris, 3 rd March, 2026 Progress against FOCUS-27 in a deteriorating environment Accelerated transformation to strengthen the operating model Full-year 2025 results €848.2 million net sales (7.0) % decline [...]
Sympathiq Launches Well-Being Marketplace Connecting UK Residents with Certified Mental Health Specialists
03/03/2026
London, UK, March 03, 2026 (GLOBE NEWSWIRE) -- Sympathiq Ltd , a digital health technology company, announced today the launch of its online well-being marketplace, designed to connect residents across the United [...]
Testosterone Booster Supplement for Men Over 50 — TestoPrime Medically Accredited by Clinicians' Choice in 2026
03/03/2026
As of March 2026, TestoPrime is available in over 130 countries and holds the Clinicians' Choice medical accreditation as natural testosterone supplement for men. New York City, NY, March 03, 2026 (GLOBE NEWSWIRE) -- [...]
Suzanne Nora Johnson Joins Wellcome Leap Board of Directors
03/03/2026
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Wellcome Leap (Leap), a U.S. nonprofit founded by the Wellcome Trust to accelerate breakthroughs in human health, today announced that Suzanne Nora Johnson has joined its [...]
Inteleos 2026 Leadership Elections Accelerate Vision for Global Healthcare
03/03/2026
New leadership across the Board and Councils align with the organization’s fifty-year legacy and strategic policy ROCKVILLE, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Inteleos today announced its 2026 leadership elections [...]
PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm, an AI-Powered Pathology Solution to Transform Dermatopathology Workflow
03/03/2026
BOSTON, March 03, 2026 (GLOBE NEWSWIRE) -- PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted [...]
Hot Springs Arkansas Neurologist Kara Way Opens New Way Neurology
03/03/2026
HOT SPRINGS, Ark., March 03, 2026 (GLOBE NEWSWIRE) -- New Way Neurology is now open and serving patients at 100 Ridgeway St., Suite 2, in Hot Springs. The new practice is led by Board-certified neurologist Kara Way, MD [...]
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial
03/03/2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet [...]
Tekton Research Appoints Dr. Jara McDonald as Executive Medical Director to Support Continued Growth in Cardiometabolic Research
03/03/2026
Double Board-Certified Obesity, Diabetes & Integrative Medicine Specialist to Lead Medical Strategy, Sponsor Engagement, and Industry Collaboration AUSTIN, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Tekton Research, [...]
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
03/03/2026
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care [...]
Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing
03/03/2026
Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”), a Delaware-incorporated, clinical-stage oncology biotechnology company, today announced its official launch following a [...]
Exagen Inc. to Participate in Upcoming Investor Conferences
03/03/2026
CARLSBAD, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following investor conferences: KeyBank [...]

Pages